Cargando…
Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPARγ/NF-κB/IL-6 signaling pathway
Traumatic brain injury (TBI) is the major cause of high mortality and disability rates worldwide. Pioglitazone is an activator of peroxisome proliferator-activated receptor-gamma (PPARγ) that can reduce inflammation following TBI. Clinically, neuroinflammation after TBI lacks effective treatment. Al...
Autores principales: | Deng, Yongbing, Jiang, Xue, Deng, Xiaoyan, Chen, Hong, Xu, Jie, Zhang, Zhaosi, Liu, Geli, Yong, Zhu, Yuan, Chengfu, Sun, Xiaochuan, Wang, Changdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083749/ https://www.ncbi.nlm.nih.gov/pubmed/32215295 http://dx.doi.org/10.1016/j.gendis.2019.05.002 |
Ejemplares similares
-
PP2 Ameliorates Renal Fibrosis by Regulating the NF-κB/COX-2 and PPARγ/UCP2 Pathway in Diabetic Mice
por: Wei, Jinying, et al.
Publicado: (2021) -
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys
por: Swanson, Christine R, et al.
Publicado: (2011) -
Avicularin ameliorates human hepatocellular carcinoma via the regulation of NF-κB/COX-2/PPAR-γ activities
por: Wang, Zhimin, et al.
Publicado: (2019) -
Yarrow oil ameliorates ulcerative colitis in mice model via regulating the NF‐κB and PPAR-γ pathways
por: Mohamed, Maged E., et al.
Publicado: (2021) -
Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ Activity
por: Jacques, Vincent, et al.
Publicado: (2021)